237 related articles for article (PubMed ID: 34480538)
21. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis.
Winkler R; Benz V; Clemenz M; Bloch M; Foryst-Ludwig A; Wardat S; Witte N; Trappiel M; Namsolleck P; Mai K; Spranger J; Matthias G; Roloff T; Truee O; Kappert K; Schupp M; Matthias P; Kintscher U
Diabetes; 2012 Feb; 61(2):513-23. PubMed ID: 22210316
[TBL] [Abstract][Full Text] [Related]
22. RelB/p52-mediated NF-κB signaling alters histone acetylation to increase the abundance of corticotropin-releasing hormone in human placenta.
Di Stefano V; Wang B; Parobchak N; Roche N; Rosen T
Sci Signal; 2015 Aug; 8(391):ra85. PubMed ID: 26307012
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.
Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ
Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192
[TBL] [Abstract][Full Text] [Related]
24. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
Schürmann C; Linke A; Engelmann-Pilger K; Steinmetz C; Mark M; Pfeilschifter J; Klein T; Frank S
J Pharmacol Exp Ther; 2012 Jul; 342(1):71-80. PubMed ID: 22493041
[TBL] [Abstract][Full Text] [Related]
25. Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia.
Barbati SA; Colussi C; Bacci L; Aiello A; Re A; Stigliano E; Isidori AM; Grassi C; Pontecorvi A; Farsetti A; Gaetano C; Nanni S
Endocrinology; 2017 Jul; 158(7):2391-2405. PubMed ID: 28368536
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone-induced suppression of steroidogenic acute regulatory protein gene expression in mouse Y-1 adrenocortical cells is associated with reduced histone H3 acetylation.
Fon WP; Li PH
Endocrine; 2007 Oct; 32(2):155-65. PubMed ID: 18040891
[TBL] [Abstract][Full Text] [Related]
27. DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity.
Yeh KC; Yeh TK; Huang CY; Hu CB; Wang MH; Huang YW; Chou LH; Ho HH; Song JS; Hsu T; Jiaang WT; Chao YS; Chen CT
Life Sci; 2021 Aug; 278():119574. PubMed ID: 33961850
[TBL] [Abstract][Full Text] [Related]
28. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.
Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964
[TBL] [Abstract][Full Text] [Related]
29. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
30. The nonglycemic actions of dipeptidyl peptidase-4 inhibitors.
Kim NH; Yu T; Lee DH
Biomed Res Int; 2014; 2014():368703. PubMed ID: 25140306
[TBL] [Abstract][Full Text] [Related]
31. Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.
Willard JR; Barrow BM; Zraika S
Diabetologia; 2017 Apr; 60(4):701-708. PubMed ID: 27933334
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
[TBL] [Abstract][Full Text] [Related]
33. Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice.
O'Harte FP; Mooney MH; Kelly CM; McKillop AM; Flatt PR
Regul Pept; 2001 Jan; 96(3):95-104. PubMed ID: 11111014
[TBL] [Abstract][Full Text] [Related]
34. Histone acetylation determines transcription of atypical protein kinases in rat neurons.
Borodinova AA; Kuznetsova MA; Alekseeva VS; Balaban PM
Sci Rep; 2019 Mar; 9(1):4332. PubMed ID: 30867503
[TBL] [Abstract][Full Text] [Related]
35. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
[TBL] [Abstract][Full Text] [Related]
36. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.
Varin EM; Hanson AA; Beaudry JL; Nguyen MA; Cao X; Baggio LL; Mulvihill EE; Drucker DJ
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663193
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of dipeptidyl peptidase IV by novel inhibitors with pyrazolidine scaffold.
Cheon HG; Kim SS; Kim KR; Rhee SD; Yang SD; Ahn JH; Park SD; Lee JM; Jung WH; Lee HS; Kim HY
Biochem Pharmacol; 2005 Jul; 70(1):22-9. PubMed ID: 15893294
[TBL] [Abstract][Full Text] [Related]
39. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
[TBL] [Abstract][Full Text] [Related]
40. Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.
Dawwas GK; Smith SM; Park H
Cardiovasc Diabetol; 2018 Jul; 17(1):102. PubMed ID: 30016946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
